Stay updated on Durvalumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedA new version entry (33) dated 2026-04-30 with changes to Study Status and Contacts/Locations was added to the record history; the 2026-02-10 entry was deleted.SummaryDifference0.3%

- Check11 days agoChange DetectedAdded Revision: v3.5.3 and removed Revision: v3.5.2, reflecting a minor platform update to the page's version label.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed. This is a minor labeling update to the page's metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.0 was added to the record history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the version history.SummaryDifference0.1%

- Check89 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and the version history shows 32 with Revision: v3.4.2. The page also removes a government funding operating status notice from the previous version.SummaryDifference0.8%

Stay in the know with updates to Durvalumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.